Bessemer Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-357,577
Closed -$6.76M 1933
2022
Q1
$6.76M Hold
357,577
0.01% 237
2021
Q4
$12.5M Hold
357,577
0.03% 200
2021
Q3
$13.1M Hold
357,577
0.03% 210
2021
Q2
$14M Sell
357,577
-451
-0.1% -$13K 0.03% 217
2021
Q1
$10.1M Buy
358,028
+82,682
+30% +$2.64M 0.02% 224
2020
Q4
$8.82M Hold
275,346
0.02% 220
2020
Q3
$8.89M Buy
+275,346
New +$8.58M 0.03% 218

Other funds holding HCM

Bessemer Group's HCM Position: Q2 2022 in Review

Bessemer Group sold out of HUTCHMED (HCM) in Q2 2022, closing a stake of 357,577 shares — an estimated $6.76M sold.

Bessemer Group first reported a position in HCM in Q3 2020 and held it in 7 quarters. The position peaked at $14M in Q2 2021. 116 funds tracked by Wall St. Rank hold HCM as of Q2 2022.

  • Bessemer Group reported no remaining HUTCHMED position as of Q2 2022 after selling out during the quarter.
  • Bessemer Group sold 357,577 HUTCHMED shares in Q2 2022, an estimated $6.76M.
  • Bessemer Group first reported a position in HUTCHMED in Q3 2020 and held it in 7 quarters.
  • Bessemer Group's HUTCHMED position peaked at $14M in Q2 2021.
  • 116 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2022.

Based on Bessemer Group's 13F filing for Q2 2022, filed 10 Aug 2022.